Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.
Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ ...
"As a healthcare company with a disease-centric approach, we are improving the standard of care in a broad range of diseases with high unmet need, including multiple myeloma, lung cancer, inflammatory ...
We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best cheap stocks to ...
Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...
Maranda Johnson is a real estate agent, entrepreneur and reality TV star known for her relationship with rapper Kodak Black. Here's everything you need to know.
From new leadership to product launches, here are five key updates from spine and orthopedic devicemakers since Jan. 15.
(Reuters) - Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects ...
Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...
The New Brunswick, N.J.-based company (JNJ) had per-share earnings of $1.41 for the quarter, down from $1.70 a year ago. Adjusted for one-time items, EPS came to $2.04, ahead of the $1.99 FactSet ...
Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (Nasdaq: BDRX), a clinical ...
Loblaw divests 42 Wellwise by Shoppers stores to Verillium Health Care, focusing on pharmacy growth as the healthcare brand ...